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INTRODUCTION
Ovary banking is a developing method designed to
save fertility in females under threat of premature ova-
rian failure [2, 16, 19]. It involves cryopreservation of
the ovaries with the option of transplantation. Reports
on the transplantation of cryopreserved ovaries illus-
trate the resumption of the hypothalamic–pituitary–ova-
rian axis [11], follicle development [4, 21], and even
successful pregnancies [5, 22]. However, deficiency of
the activity of steroid production drive from recipients
relevant to ovariectomy or premature ovarian failure,
as well as organ loss due to procedural steps, is expect-
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This study evaluates the effect of melatonin on follicular dynamics in neonate
vitrified ovarian grafts. Vitrified ovaries from neonate F1 hybrid mice, candi-
dates for transplantation to treated or non-treated groups, were thawed under
standard conditions with or without the addition of 100 µM melatonin, respec-
tively. Following transplantation, melatonin (20 mg/kg/day) or saline solution
was injected i.p. into the treated and the non-treated groups, respectively.
Vaginal cytology to monitor estrogenic activity together with follicle survival
and development in the ovary grafts was examined.
The results showed that the sites of transplantation became obvious within the
oestrous phase. Histological analysis showed that there was a dynamic of the
ovogenesis process in the vitrified ovary grafts. However, in the ovary graft the
empty cavity together with jumbled oocyte-granulosa complex in the non-treat-
ed group was higher than in the melatonin treated group.
Overall, the number of primary follicles in the ovary grafts of both groups re-
mained constant throughout the oestrous period. However, the treated ovary
grafts contained more secondary follicles throughout the oestrous period in
comparison to non-treated ovary grafts. The antral follicle rates were more
marked in the melatonin treated group than in the non-treated group during
the oestrous period, whereas at other days of the cycle no significant differ-
ence was observed. The fresh corpora lutea rates were significantly higher in
the treatment group than in the non-treatment group.
The study showed that there is a positive effect with melatonin resulting in
more grafts restoring puberty. Furthermore, the associated increase in healthy
follicles suggests that melatonin has a preventative ischaemia/antioxidant ac-
tion and may be useful to follicles. (Folia Morphol 2011; 70, 1: 18–23)
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ed to have had negative effects on the reproductive
potential of cryopreserved-warmed ovarian grafts; there-
fore, the future of ovarian transplantation will depend
on follow up and making a healthy situation for it in
the host during the post grafting time. Recent reports
from studies on improving the quality of ovarian grafts
have confirmed that administration of melatonin im-
proved the follicular development of ovarian grafts [6,
7]. Melatonin is a hormone synthesized in the pineal
gland and other organs such as lacrimal and retina [13,
17]. Recently it was shown that the ovary can produce
melatonin as well [8]. Moreover, it was reported that
melatonin reduces the elevated gonadotropins and re-
gulates the disturbance of endocrine oestrous cycle func-
tion observed in menopausal females as well as ova-
riectomized hosts of vitrified ovary grafts into the phy-
siological conditions of mature females [7]. Therefore,
melatonin could be considered as a substance to im-
prove the dynamic process of follicles in the ovarian
graft during the oestrous period. Previous reports have
shown direct effects of variable melatonin regimen on
the folliculogenesis and oogenesis of in vitro cultured
ovarian follicles [1]. Melatonin also protects the ovaries
against oxidative damage associated with reperfusion
following an ischaemic insult [26]. However, there has
been no report on the protective effect of melatonin on
follicular dynamic of oestrous cyclicity in vitrified ova-
rian grafts yet. Therefore, we conducted a study in
a mouse model to investigate whether the administra-
tion of melatonin (the optimum dose of melatonin from
our dose-finding study, unpublished data) before the
cryopreservation process and after transplantation has




Melatonin (Helsinn Advanced Synthesis SA, Bias-
ca and Sigma Chemicals, Buchs, Switzerland) was
used for treatment by i.p. (intra-peritoneal) injection.
Animals
These experiments were carried out in accordance
with the Ahvaz University Guide for the Care and
Use of Laboratory Animals. Ten-day-old female
(CBA × C57Bl/6) F1 hybrid mice were used as ovarian
donors and 8–10 week-old females of the same strain
were used as ovarian recipients (Pasture Institute of Iran).
Recipient mice were randomly assigned either as con-
trol (group I) or treated (group II). Group I obtained
physiological saline, and Group II received melatonin
(20 mg/kg/day). Each of the groups was further dis-
tributed randomly into six subgroups. The recipient
mice in each subgroup sacrificed at day diestrous 1
(n = 6), prestrous (n = 6), estrous (n = 6), metestrous
(n = 6), or diestrous 2 (n = 6). As sham, for each sub-
group, the same number mice were sham operated:
After anaesthesia, the ovaries were visualized and re-
placed. These sham mice did not receive any graft.
Ovary vitrification
Intact ovaries of ten-day-old mice were recovered
and vitrified as previously published [12], with the fol-
lowing modifications: medium containing 40% ethy-
lene glycol (v/v), 30% ficoll 70 (w/v), and 1 M sucrose
supplemented with foetal bovine serum (EFS40) (Sig-
ma-Aldrich, USA). Whole ovaries were exposed to in-
creasing concentrations of vitrification solution (VS)
(12.5, 25, 50, and 100%). The first two steps lasted
5 minutes at room temperature, and the next two for
15 minutes at 4°C. Each of the ovaries was then trans-
ferred into 1.8 mL cryogenic vials (Nunc, Roskilde, Den-
mark) containing EFS40. The vials were transferred
directly into liquid nitrogen at –196°C. Before grafting,
the ovaries were rapidly warmed in air at room temper-
ature for 30 seconds and then immersed in water at
30–35°C for 5 minutes. The ovaries were removed from
the cryovials and placed successively in solutions con-
taining decreasing VS concentrations (50, 25, and
12.5%) and finally washed in aMEM.
Melatonin treatment in vitro
The thawed ovaries were further incubated for
30 minutes in aMEM plus 10% FBS, with or without
100 µM additive melatonin, before being transplant-
ed subcutaneously on the back of ovariectomized
recipients of treatment (group II) or no treatment
(group I), respectively.
Ovary transplantation
At first, ovariectomy was performed by excision
between the uterine horn and the fallopian. The in-
tact vitrified thawed ovaries were subsequently in-
serted bilaterally into the subcutaneous-site (into
adipose; bilaterally adjacent to the midline) on the
back of recipient mice. Sham animals were subject-
ed to surgery without implantation of ovary.
Melatonin treatment in vivo
After transplanting, melatonin 20 mg/kg/day was
applied by intraperitoneal (i.p.) injections in 0.2 mL
of 0.9% saline to the host mice (group I) once a day
at 18:00 h (1 h before initiation of 12 h dark phase)
for up to 48 h. Group II received only saline. Treat-
ment was started 1–4 h after transplantation.
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Histology staining
Ovaries fixed in 4% buffered formaldehyde (37%
Formaldehyde, Merck, Germany) were embedded in
paraffin blocks, and the whole ovary was sectioned
serially at 4 mm thickness. Three sequential sections
were put on each slide. The slides were stained with
haematoxylin and eosin (Sigma-Aldrich, USA).
Ovarian histology and follicle counting
Follicle count and categorization was carried out
as previously published [18], using ovarian serial sec-
tions of both groups. With the exception of primor-
dial follicles, both healthy and atretic follicles were in-
cluded in the study. The follicles were divided into four
groups based on their number, the form of the layers
of follicular cells, and by the presence (or absence) of
an antral cavity: primary follicle (one layer of cuboidal
granulosa cells), second follicle (more than one layer
of cuboidal granulosa cells without an antral cavity),
antral follicles (with an antral cavity), and preovulato-
ry follicle (with a large antral cavity). Within the ovary,
two forms of follicle loss can be distinguished [18].
Atretic follicles were detected by granulosa cell apop-
tosis. Atretic follicles were identified by the presence
of pyknotic nuclei of oocyte [3, 14]. In addition, the
number of fresh corpora lutea, i.e. corpora lutea formed
during the last ovarian cycle, was counted in serial sec-
tions of ovaries collected on the day of oestrus. Newly
formed corpora lutea can be distinguished from older
ones by their irregular size and the morphology of the
granulosa luteal cells [18]. All sections were examined
by light microscopy. The photographed examined sec-
tions (approximately every tenth section) were scored
by NIH Image software.
Statistical analysis
Two-way variance analysis was used to compare
the mean numbers of follicles from Group I and
Group II. The proportion of follicles in different de-
velopmental stages was compared by means of
c2 test. Results are expressed as mean ± SE. A p value
< 0.05 was considered significant.
RESULTS
General observations of transplanted
vitrified-warmed ovaries throughout
the oestrous phase
The sites of transplantation were swollen and be-
came obvious within the oestrous phase (Fig. 1). His-
tological analysis showed complete ovogenesis in the
grafts of neonate ovaries, which formerly had primor-
dial follicles. The dynamics of the ovogenesis process
were equal to the follicular dynamic which takes place
in the mature ovary during the oestrous cycle. Howev-
er, in the ovary graft the empty cavity together with
jumbled oocyte-granulosa complex,  sloughing of granu-
losa cells and the messy appearance of interstitial in
non-treated group was higher than in melatonin treat-
ed group (Fig. 2).
Evaluation of the effect of melatonin on ovarian
graft follicles within the oestrous phase
An outline of the statistics obtained is shown in
Figure 3. Overall, there were significant differences
in the total number of follicles obtained from the
control (n = 321) and melatonin treated (n = 556)
ovary grafts at the first oestrous phase after trans-
Figure 1. Representative micrograph of subcutaneous site of
ovary graft in host mice (arrow). Note the presence of revascularisa-
tion surrounding the transplant site to provide enough blood to
the graft.
Figure 2. Histological cross-section of grafted neonate ovary
retrieved from treatment recipients 32 days after transplantation:
Section of ovary showing normal oogenesis. Note the presence
of the empty cavity (arrow) and the messy interstitial appearance,
leading to a heterogeneous appearance of the ovary.
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plantation. When the oestrous cycle in both groups
was stratified by the most type of follicles which
were observed at certain days of the oestrous cy-
cle, it was shown that secondary follicles and an-
tral follicles were detected at proestrous and
oestrous stages in most ovary grafts, respectively.
However, the number of primary follicles in ovary
grafts of both groups stayed steady throughout
the oestrous period (Fig. 3). With respect to the
A B
primary follicles, treated ovary grafts contained
more follicles throughout the oestrous period in
comparison to non-treated ovary grafts (p ≥ 0.001
for secondary follicles during proestrous, oestrous,
metestrous, diaestrous p ≥ 0.001 for antral folli-
cles within proestrous, oestrous) (Fig. 3). General-
ly, in the oestrous cycle, the ovary grafts of the treat-
ed group had a higher rate of growing follicles than
the non-treated group.
Figure 3. Follicular distribution in grafted neonate ovaries on different days of the oestrous period. Data are shown as mean + SEM; p-values com-
pared among treated and non-treated groups;***p  < 0.001. For comparison to non-treated group; T — treated group; N — non-treated group;
P — prestrous; E — estrous; M — metestrous; D1 — 1st day of diestrous; D2 — 1st day of diestrous.
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Evaluation of the effect of melatonin
on preovulatory follicles
The number of fresh corpora lutea was counted
in both groups on the day of oestrous as a reflec-
tion of the number of ovulations during the last
oestrous phase. The mean number of fresh corpora
lutea present was higher in the treatment group
(9.8 ± 0.5) then in the non-treatment group (7.8 ± 0.8;
p ≥ 0.05).
DISCUSSION
Recently it was shown that melatonin adminis-
tration not only has not been disorder the circadian
rhythm of melatonin levels in ovariectomized mice
but also may decrease the elevated gonadotropin se-
cretions in the ovariectomized mice to levels similar
to those of intact mice [7]. Also, melatonin caused
the characteristics of sex steroids to be modified in
the ovariectomized mice which received the neonate
ovaries as a mechanism that takes place throughout
the oestrous cycle of adult intact mice [7].
Moreover, it was reported that melatonin could
improve the development of primordial follicles to
the next stage and help them undergo the full range
of morphological changes associated with oocyte
maturation in neonate ovary grafts [6]. The present
study revealed that the distribution of variable grow-
ing follicles in ovarian grafts which were obtained
from melatonin treated/non-treated host mice
throughout the oestrous cycle were different as well.
Examination of follicles during the oestrous cycle
showed that melatonin might increase the number
of secondary follicles at the proestrous time, con-
firming the role of melatonin in initial follicle recruit-
ment [1, 10]. Indeed, in the oestrous phase, the
number of antral follicles of ovarian grafts in the
non-treated group was lower than those of the
melatonin treated group. This implies that oestra-
diol secretions in non-treated host mice are lower
than those of treated mice. Because oestradiol is
mainly produced by the antral follicles [20]. Further-
more, the number of corpora lutea, as a reflection
of the number of pre-ovulatory follicles at last
oestrous period in treated group, was higher than
in the non-treated group. The presence of more fol-
licles at the appropriate stage in treated ovarian
grafts could explain this enhanced recruitment. How-
ever, it is also possible that the lower number of
follicles in non-treated ovarian grafts display an in-
creased sensitivity toward follicle stimulating hor-
mone (FSH). Melatonin and its type II receptor dis-
play a similar expression pattern being expressed in
growing follicles with higher expression in the se-
condary and the antral follicles than in the primary
follicles [1, 23, 24]. This window of melatonin ex-
pression is also reflected by the melatonin serum
levels, which showed a small but significant increase
during the oestrous period, correlating with the in-
creased number of secondary and antral follicles [15].
Thus, in the non-treated host mice, the lower FSH
levels were sufficient to recruit the primary follicles
because the absence of melatonin renders the folli-
cles more sensitive to FSH [25]. FSH sensitivity of
primary follicles is similar in melatonin treated and
non-treated mice because the melatonin type II re-
ceptor is not expressed in follicles at this stage [23,
24]. As a result, FSH levels in non-treated host mice
are too low to support the follicles for dominance,
and a normal number of ovulations ensue. Indeed,
a rise in FSH levels in a superovulation scheme de-
monstrated that treated follicles of ovarian grafts can
be rescued and supported to the preovulatory stage,
resulting in a large increase in the number of retrieved
oocytes in treated mice, compared with non-treated
host mice. It has been shown that the increased num-
ber of follicles capable of ovulating upon melatonin
administration reflects a reduction in the number of
follicles undergoing atresia [9]. Indeed, the number
of oocytes retrieved in both treated and non-treated
mice corresponds with the total number (non-healthy
and healthy) of antral follicles observed during
oestrous time.
Therefore, further experiments are necessary to
identify the mechanisms of the effects of melatonin
treatment on follicular dynamics and the secretion
of oestradiol in neonate vitrified ovarian grafts after
host treatment with melatonin, and we suggest that
other researchers identify the precise expression of
melatonin type I and II receptors and plasma con-
centration of oestradiol during the influence of me-
latonin on the transplantation/fertility complication.
CONCLUSIONS
In conclusion, our results revealed that a cause-
effect relationship between the administration of
melatonin and the distribution of variable growing
follicles in ovarian grafts during the oestrous cycle
may in fact exist. The follow up controls show that
melatonin enhanced recruitment, increased follicle-
related neurovegetative disturbances, and restored
menstrual cyclicity and fertility in host females. At
present we can assert that the treatment with me-
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latonin produced a remarkable and highly signifi-
cant improvement of ovarian graft function and
positive changes of development follicles towards
more preovulatory follicles.
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